M. Braccioforte

发表

The risk of death from prostate cancer in men with Gleason score 3+4 prostate cancer treated using brachytherapy with or without a short course of androgen deprivation therapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2021, Urologic oncology.

Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low- or intermediate-risk disease.

A. D'Amico, J. Moul, N. Arvold, 2011, Journal of Clinical Oncology.

Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features

A. Kishan, A. D'Amico, B. Trock, 2021, JAMA network open.

Comorbidity and the Receipt of Curative Therapy for Favorable-risk Prostate Cancer Prior to and Following the Publication of PIVOT.

A. D'Amico, Ming-Hui Chen, B. Moran, 2016, European urology focus.

Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.

A. D'Amico, Ming-Hui Chen, B. Moran, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diabetes mellitus, race, and the odds of high-grade prostate cancer in men diagnosed with prostate cancer in the United States.

A. D'Amico, B. Moran, M. Chen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer.

A. D'Amico, Ming-Hui Chen, B. Moran, 2011, International journal of radiation oncology, biology, physics.

Clinical Investigation : Genitourinary Cancer The Number of High-Risk Factors and the Risk of Prostate Cancer e Specific Mortality After Brachytherapy : Implications for Treatment Selection

A. D'Amico, Ming-Hui Chen, J. Moul, 2012 .

Association of androgen‐deprivation therapy with excess cardiac‐specific mortality in men with prostate cancer

A. D'Amico, Ming-Hui Chen, Jim C Hu, 2015, BJU international.

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate‐risk disease

A. D'Amico, Ming-Hui Chen, B. Moran, 2015, Cancer.

Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery disease.

A. D'Amico, Ming-Hui Chen, B. Moran, 2014, European urology.

Androgen‐suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke

A. D'Amico, Ming-Hui Chen, T. Choueiri, 2010, BJU international.

Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, International journal of radiation oncology, biology, physics.

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients.

Ming-Hui Chen, T. Choueiri, K. Hoffman, 2015, International journal of radiation oncology, biology, physics.

Hormonal therapy or external-beam radiation with brachytherapy and the risk of death from prostate cancer in men with intermediate risk prostate cancer.

A. D'Amico, Ming-Hui Chen, J. Rosenberg, 2012, Clinical genitourinary cancer.

Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction.

A. D'Amico, P. Kantoff, Ming-Hui Chen, 2012, International journal of radiation oncology, biology, physics.

Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2013, International journal of radiation oncology, biology, physics.

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.

A. D'Amico, Ming-Hui Chen, B. Moran, 2009, JAMA.

Stereotactic transperineal prostate biopsy.

B. Moran, M. Braccioforte, 2009, Urology.

Re-biopsy of the prostate using a stereotactic transperineal technique.

B. Moran, M. Braccioforte, D. Conterato, 2006, The Journal of urology.

Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, International journal of radiation oncology, biology, physics.

Luteinizing-hormone Releasing Hormone Therapy and the Risk of Death From Alzheimer Disease

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, Alzheimer disease and associated disorders.

Long-term biochemical outcomes using cesium-131 in prostate brachytherapy.

B. Moran, N. Amin, S. Rice, 2019, Brachytherapy.

Cesium-131 prostate brachytherapy: An early experience

B. Moran, M. Braccioforte, 2007 .

Surgery vs Radiotherapy in the Management of Biopsy Gleason Score 9-10 Prostate Cancer and the Risk of Mortality

A. D'Amico, Ming-Hui Chen, M. Graefen, 2019, JAMA oncology.

Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, International journal of radiation oncology, biology, physics.

Risk Group and Death From Prostate Cancer Among Men Undergoing Brachytherapy

A. D'Amico, Ming-Hui Chen, A. Raldow, 2015 .

Risk Group and Death From Prostate Cancer: Implications for Active Surveillance in Men With Favorable Intermediate-Risk Prostate Cancer.

A. D'Amico, Ming-Hui Chen, A. Raldow, 2015, JAMA oncology.

Risk of death from prostate cancer after radical prostatectomy or brachytherapy in men with low or intermediate risk disease.

A. D'Amico, Ming-Hui Chen, J. Moul, 2011, The Journal of urology.

The use of supplemental external beam radiotherapy in men with low-risk prostate cancer undergoing brachytherapy before and after the 1999 American Brachytherapy Society Guideline statement.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, Brachytherapy.

Predictors of the use of supplemental androgen suppression therapy and external beam radiation in men with high-risk prostate cancer undergoing brachytherapy in community practice.

A. D'Amico, Ming-Hui Chen, B. Moran, 2011, Brachytherapy.

Long-term outcomes analysis of low-dose-rate brachytherapy in clinically T3 high-risk prostate cancer.

B. Moran, N. Amin, J. Molitoris, 2018, Brachytherapy.

Gleason Score 3 + 5 or 5 + 3 versus 4 + 4 Prostate Cancer: The Risk of Death.

A. D'Amico, Ming-Hui Chen, B. Moran, 2016, European urology.

Prostate cancer‐specific mortality and the extent of therapy in healthy elderly men with high‐risk prostate cancer

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, Cancer.

Brachytherapy monotherapy may be sufficient for a subset of patients with unfavorable intermediate risk prostate cancer.

A. D'Amico, Ming-Hui Chen, Ivan Buzurovic, 2017, Urologic oncology.

Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.

A. Kishan, P. Boutros, D. Song, 2021, European urology.

Race and mortality risk after radiation therapy in men treated with or without androgen‐suppression therapy for favorable‐risk prostate cancer

A. D'Amico, Ming-Hui Chen, B. Moran, 2016, Cancer.

Influence of Comorbidity on the Risk of Mortality in Men With Unfavorable-Risk Prostate Cancer Undergoing High-Dose Radiation Therapy Alone.

A. D'Amico, Ming-Hui Chen, B. Moran, 2016, International journal of radiation oncology, biology, physics.

Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable-risk prostate cancer

A. D'Amico, Ming-Hui Chen, M. Dyer, 2016, Journal of Radiation Oncology.

Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.

A. D'Amico, Ming-Hui Chen, A. Raldow, 2015, Brachytherapy.

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size.

A. D'Amico, P. Kantoff, Jim C Hu, 2011, International journal of radiation oncology, biology, physics.

Comparison of Health Related Quality of Life and Other Clinical Parameters between 20 g and 18 g Needles for Permanent Low-Dose-Rate Implantation in Localized Prostate Cancer

B. Moran, M. Braccioforte, 2014 .

Urinary Morbidity Following Cs-131 Brachytherapy for Localized Prostate Cancer

B. Moran, M. Braccioforte, 2007 .

Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy.

A. D'Amico, Ming-Hui Chen, B. Moran, 2011, The Journal of urology.

Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.

A. D'Amico, Ming-Hui Chen, B. Moran, 2009, JAMA.

Androgen Deprivation Therapy Use in the Setting of High-dose Radiation Therapy and the Risk of Prostate Cancer-Specific Mortality Stratified by the Extent of Competing Mortality.

A. D'Amico, Ming-Hui Chen, B. Moran, 2016, International journal of radiation oncology, biology, physics.

Short-course androgen deprivation therapy and the risk of death from high-risk prostate cancer in men undergoing external beam radiation therapy and brachytherapy.

A. D'Amico, Ming-Hui Chen, A. Raldow, 2015, Brachytherapy.

Risk of death from prostate cancer after brachytherapy alone or with radiation, androgen suppression therapy, or both in men with high-risk disease.

A. D'Amico, Ming-Hui Chen, B. Moran, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Influence of androgen deprivation therapy on all-cause mortality in men with high-risk prostate cancer and a history of congestive heart failure or myocardial infarction.

A. D'Amico, P. Kantoff, Ming-Hui Chen, 2012, International journal of radiation oncology, biology, physics.

Letters to the Editor/Errata Re: Risk of Death From Prostate Cancer After Radical Prostatectomy or Brachytherapy in Men With Low or Intermediate Risk Disease

J. Moul, B. Moran, M. Chen, 2012 .

Hormonal therapy or external-beam radiation with brachytherapy and the risk of death from prostate cancer in men with intermediate risk prostate cancer.

A. D'Amico, Ming-Hui Chen, J. Rosenberg, 2010, Clinical genitourinary cancer.

Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer.

A. D'Amico, Ming-Hui Chen, B. Moran, 2010, International journal of radiation oncology, biology, physics.